中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
  4. 新药研究国家重点实验室
A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage

文献类型：期刊论文

作者Huang, Suling1; Wu, Yanwei2; Zhao, Zhuohui1,3; Wu, Bing2,3; Sun, Kai1,3; Wang, Haoyu2,3; Qin, Li1; Bai, Fang2,3; Leng, Ying1; Tang, Wei2
刊名METABOLISM-CLINICAL AND EXPERIMENTAL
出版日期2021-07-01
卷号120页码:12
关键词Macrophage NLRP3 inflammasome Hepatic lipid accumulation NASH FXR
ISSN号0026-0495
DOI10.1016/j.metabol.2021.154797
通讯作者Leng, Ying(yleng@simm.ac.cn) ; Tang, Wei(tangwei@simm.ac.cn)
英文摘要Objective: Obeticholic acid (OCA) has been proved to play potential therapeutic effect on nonalcoholic steatohepatitis (NASH). Up to now, the study of OCA on NLRP3 inflammasome activation in macrophage is still blank and merits great attention. Here, we aimed to better characterize the role and mechanism of OCA on NASH treatment focusing on NLRP3 inflammasome activation in macrophages. Methods: The effects of OCA on inflammasome activation were investigated in BMDM, Kupffer cell, BMDC and LX2 cell. Preconditioned media from BMDM culture was used to treat primary hepatocytes to explore the effects of macrophage NLRP3 inflammasome activation on the function of hepatocytes. In vivo, high fat diet plus CCl4 (DIO + CCl4) induced murine NASH model and choline-deficient and amino acid-defined (CDA) diet-induced NASH mice were used to verify the inhibitory effect of OCA on inflammasome activation in liver macrophages and recapitulate its protective role on NASH progressing. To clear up the effect of OCA on macrophage is FXR dependent or not, FXR siRNA was introduced into BMDMs. Results: OCA blockaded NLRP3 inflammasome in BMDMs by impacting on the activation stage and disrupting ASC oligomerization. Preconditioned supernatant from LPS + ATP treated BMDMs increased mRNA expression of lipogenic enzymes and lipid content, whereas preconditioned supernatant from OCA treated BMDM blocked these effects in both normal and the FXR knockdown hepatocytes. In DIO + CCl4 mice, the population of inflammatory myeloid lineage cells in livers was decreased upon OCA treatment. Accordingly, the level of IL-1 beta and IL-18 in liver, the hepatic expression of ASC, pro-caspase-1 and active caspase-1, the expression of caspase 1 p20 in liver macrophages were also reduced. Similar results were obtained in CDA diet-fed mice. Furthermore, OCA maintained the inhibition on NLRP3 inflammasome activation in FXR knockdown BMDMs, suggesting FXR could be dispensable in this effect. Conclusions: This finding brings up a new mechanism of OCA on NASH treatment, suggested by direct inhibition on NLRP3 inflammasome activation in macrophage, further suppression on inflammasome activation-elicited hepatic lipid accumulation, and contributing to the amelioration of NASH. (C) 2021 Elsevier Inc. All rights reserved.
WOS关键词NONALCOHOLIC STEATOHEPATITIS ; LIVER INFLAMMATION ; FIBROSIS ; DIET
资助项目Shanghai Committee of Science and Technology, China[20ZR1468300] ; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences[SIMM2004KF-15]
WOS研究方向Endocrinology & Metabolism
语种英语
WOS记录号WOS:000662264900006
出版者W B SAUNDERS CO-ELSEVIER INC
源URL[http://119.78.100.183/handle/2S10ELR8/297123]  
专题新药研究国家重点实验室
通讯作者Leng, Ying; Tang, Wei
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Lab Antiinflammat, Shanghai 201203, Peoples R China
3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
推荐引用方式
GB/T 7714		 Huang, Suling,Wu, Yanwei,Zhao, Zhuohui,et al. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage[J]. METABOLISM-CLINICAL AND EXPERIMENTAL,2021,120:12.
APA Huang, Suling.,Wu, Yanwei.,Zhao, Zhuohui.,Wu, Bing.,Sun, Kai.,...&Tang, Wei.(2021).A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.METABOLISM-CLINICAL AND EXPERIMENTAL,120,12.
MLA Huang, Suling,et al."A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage".METABOLISM-CLINICAL AND EXPERIMENTAL 120(2021):12.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。